HighTower Advisors’s Akoya BioSciences AKYA Stock Holding History

HighTower Advisors’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$26K	–	3817
2025 Q2	$26K	Hold	20,000	–	–	﹤0.01%	3602
2025 Q1	$27.8K	Hold	20,000	–	–	﹤0.01%	3499
2024 Q4	$45.8K	Sell	20,000 -200	-1%	-$530	﹤0.01%	3463
2024 Q3	$55K	Sell	20,200 -7,000	-26%	-$17.1K	﹤0.01%	3400
2024 Q2	$63K	Hold	27,200	–	–	﹤0.01%	3276
2024 Q1	$128K	Hold	27,200	–	–	﹤0.01%	3091
2023 Q4	$133K	Sell	27,200 -3,750	-12%	-$15.6K	﹤0.01%	3130
2023 Q3	$144K	Buy	30,950 +19,922	+181%	+$114K	﹤0.01%	3017
2023 Q2	$81K	Buy	+11,028	New	+$73.6K	﹤0.01%	3112

HighTower Advisors's AKYA Position: Q3 2025 in Review

HighTower Advisors sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 20,000 shares — an estimated $26K sold.

HighTower Advisors first reported a position in AKYA in Q2 2023 and held it in 9 quarters. The position peaked at $144K in Q3 2023. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

HighTower Advisors reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
HighTower Advisors sold 20,000 Akoya BioSciences shares in Q3 2025, an estimated $26K.
HighTower Advisors first reported a position in Akoya BioSciences in Q2 2023 and held it in 9 quarters.
HighTower Advisors's Akoya BioSciences position peaked at $144K in Q3 2023.
0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.